Mind Medicine (MNMD) Tops Q3 EPS by 1c

Mind Medicine (NASDAQ: MNMD) reported Q3 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight
• Evercore ISI Downgrades TE Connectivity (TEL) to In Line